6254 — Nomura Micro Science Co Balance Sheet
0.000.00%
- ¥115bn
- ¥149bn
- ¥96bn
- 40
- 64
- 53
- 53
Annual balance sheet for Nomura Micro Science Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 9,861 | 10,083 | 14,120 | 12,142 | 17,330 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 10,169 | 11,053 | 17,004 | 39,225 | 85,087 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 21,380 | 23,361 | 37,180 | 65,505 | 108,990 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,836 | 1,923 | 2,917 | 3,058 | 4,958 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 24,759 | 27,091 | 41,919 | 70,603 | 116,783 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 11,128 | 10,720 | 20,044 | 41,281 | 78,895 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 11,568 | 11,159 | 20,518 | 41,679 | 79,769 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 13,190 | 15,932 | 21,401 | 28,924 | 37,014 |
| Total Liabilities & Shareholders' Equity | 24,759 | 27,091 | 41,919 | 70,603 | 116,783 |
| Total Common Shares Outstanding |